Nicotinic Antagonists: Neuromuscular & Ganglionic Blockers
The same poison that South American hunters smeared on their arrows to drop prey in seconds now lets surgeons operate safely every single day. Neuromuscular blockers paralyse muscle on command — turning a struggling airway into a still one for intubation, and a tense abdomen into a relaxed operating field. But paralysis without sleep is a nightmare, and one of these drugs hides a rare, lethal trap. Here's how they work, and how not to be caught out.
A critically ill patient needs a breathing tube, fast. He's fighting, his jaw is clamped, and every second without a secure airway is dangerous. The anaesthetist gives a drug into the vein, and within about a minute every skeletal muscle in his body goes slack — his jaw releases, his breathing stops, and the tube slides smoothly into place. He is completely paralysed, and completely helpless, for a few minutes. This deliberate, controlled paralysis is one of the most powerful tools in medicine — and it works entirely through the nicotinic receptor at the neuromuscular junction.
Two receptors, two very different jobs
Nicotinic receptors come in two locations. Recall from the receptor map that nicotinic receptors sit in two places: at the autonomic ganglia (type NN) and at the skeletal neuromuscular junction (type NM). Blocking them gives two entirely different drug classes. Blocking the muscle receptor (NM) gives the neuromuscular blockers — the muscle relaxants of anaesthesia. Blocking the ganglionic receptor (NN) gives the ganglionic blockers — old drugs that shut down BOTH autonomic branches at once and, because of that hopeless non-selectivity, are essentially obsolete today. This article is really about the first group.
Non-depolarizing blockers: quietly blocking the door
The non-depolarizing blockers are true competitive antagonists: they sit on the nicotinic muscle receptor and block acetylcholine from acting, without stimulating it. The result is a smooth, flaccid paralysis. This group includes rocuronium, vecuronium, atracurium, and pancuronium — and the historical curare (tubocurarine), the arrow poison that started it all. Because they simply occupy the receptor, they can be REVERSED: give a cholinesterase inhibitor like neostigmine to pile up acetylcholine, which then out-competes the blocker and restores movement (paired with atropine or glycopyrrolate to block the unwanted muscarinic effects). A newer agent, sugammadex, reverses rocuronium and vecuronium by directly wrapping up and inactivating the drug molecule.
Depolarizing blockers: succinylcholine's trick
Succinylcholine works by the opposite trick. It is actually an AGONIST — it binds the nicotinic receptor and switches it on — but instead of letting go, it stays bound and holds the muscle in a persistent depolarization. The muscle can't reset to fire again, so after a brief flicker of twitches (fasciculations) it goes limp. Its gift is speed: it paralyses in under a minute and wears off in a few minutes, ideal for the rapid intubation in the opening scene. Crucially, because it acts LIKE acetylcholine, giving a cholinesterase inhibitor would make things worse, not reverse it — instead it is cleared by the plasma enzyme butyrylcholinesterase.
- Neuromuscular blockers act on the nicotinic NM receptor to paralyse skeletal muscle.
- Non-depolarizing (rocuronium, vecuronium…) = competitive antagonists; reversed by neostigmine or sugammadex.
- Succinylcholine = depolarizing agonist; fast on/off; NOT reversed by neostigmine.
- Ganglionic blockers (NN) shut down both autonomic branches — non-selective and obsolete.
Paralysis is NOT anaesthesia. Neuromuscular blockers give zero pain relief and zero sleep — they only stop muscles moving. A paralysed patient who isn't properly anaesthetized is fully aware and in agony but unable to move or cry out ('accidental awareness'). These drugs must always be given alongside adequate sedation and analgesia. It's one of the most important safety principles in all of anaesthesia.
Succinylcholine's dangerous traps
Speed comes with hazards worth memorizing. Because succinylcholine briefly opens muscle receptors, it leaks potassium out of cells and raises blood potassium — usually trivial, but dangerous (even fatal) in burns, crush injuries, and paralysis/denervation, where it can spike to a lethal level. It can trigger malignant hyperthermia, a rare but life-threatening runaway rise in temperature and muscle rigidity in genetically susceptible people (treated with dantrolene). It can cause bradycardia (especially in children or repeat doses). And in people with an inherited deficiency of butyrylcholinesterase, it isn't cleared normally, so the paralysis lasts far longer than expected — prolonged apnoea until it wears off.
- Trying to reverse succinylcholine with neostigmine. It's an agonist — that worsens the block.
- Giving a paralytic without sedation/analgesia. The patient is aware but unable to move.
- Using succinylcholine in burns/crush/denervation. Risk of lethal hyperkalemia.
- Confusing the two mechanisms. Non-depolarizers block; succinylcholine over-stimulates.
Which statement about succinylcholine is correct?
- Neuromuscular blockers paralyse skeletal muscle via the nicotinic NM receptor (anaesthesia, intubation).
- Non-depolarizing = competitive antagonists, reversed by neostigmine/sugammadex.
- Succinylcholine = fast depolarizing agonist; watch hyperkalemia, malignant hyperthermia, apnoea.
- Paralysis is not anaesthesia — always give sedation and analgesia too.
- Katzung BG. Basic & Clinical Pharmacology — Skeletal muscle relaxants & ganglion-blocking drugs.
- Brunton LL, et al. Goodman & Gilman's The Pharmacological Basis of Therapeutics — Neuromuscular blocking agents.
- Rang HP, Dale MM, et al. Rang & Dale's Pharmacology — Neuromuscular junction & blocking drugs.
- Miller RD. Miller's Anesthesia — Neuromuscular blocking drugs & reversal.
- Whalen K. Lippincott Illustrated Reviews: Pharmacology — Neuromuscular blockers.
